✦ LIBER ✦

Activity of trabectedin in germline BRCA1/2-mutated metastatic breast cancer: results of an international first-in-class phase II study

✍ Scribed by Delaloge, S.; Wolp-Diniz, R.; Byrski, T.; Blum, J. L.; Goncalves, A.; Campone, M.; Lardelli, P.; Kahatt, C.; Nieto, A.; Cullell-Young, M.; Lubinski, J.

Book ID: 125520389
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 174 KB
Volume: 25
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdu134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin activity in untreated metast

Carboplatin activity in untreated metastatic breast cancer patients — results of a phase II study

✍ K. Kolarić; D. Vukas 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 388 KB

Results of a phase II study of pemetrexe

Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer

✍ Nicholas J. Robert; Paul R. Conkling; Mark A. O’Rourke; Paul R. Kuefler; Kristi 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 234 KB

A phase II study of oral vinorelbine (NV

A phase II study of oral vinorelbine (NVBo) in first line locally advanced/metastatic breast cancer (ABC) chemotherapy. Final results

✍ V. Trillet-Lenoir; T. Delozier; M. Lichinister; D. Gédouin; P. Bougnoux 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 334 KB

5003 Phase II study of sunitinib in comb

5003 Phase II study of sunitinib in combination with trastuzumab for the treatment of metastatic breast cancer: activity and safety results

✍ J.Y. Blay; A. Lluch; M. Gutierrez; M. Martin; M.F. Kozloff; C. Prady; V. Tassell 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 70 KB

2118 POSTER A phase I study of trastuzum

2118 POSTER A phase I study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with HER2+ metastatic breast cancer

✍ I.E. Krop; M. Beeram; S. Modi; N. Rabbee; S. Girish; J. Tibbitts; S.N. Holden; S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

All-oral combination of oral vinorelbine

All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial

✍ Tubiana-Mathieu, N; Bougnoux, P; Becquart, D; Chan, A; Conte, P-F; Majois, F; Es 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 203 KB